← Back to All Filings

Zoetis Appoints Iris Knobloch to Board of Directors

Low SignificanceOctober 13, 2026 at 12:07:47 PM UTC

Zoetis Inc.

$ZTS8-KCIK: 0001555280

Subscribe to track ZTS

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Zoetis Inc. (NYSE: ZTS) Appoints Iris Knobloch to Board of Directors • Event: Appointment of Independent Director • Appointee: Iris Knobloch • Effective Date: December 1, 2026 • Board Expansion: Expands from 12 to 13 members • Committee Role: Corporate Governance Committee • Background: President of Festival de Cannes; Board Chair of Deezer S.A.; Director at Lazard, Inc. and Vail Resorts, Inc.

Comprehensive Analysis

Executive Summary

On October 8, 2026, the Board of Directors of Zoetis Inc. appointed Iris Knobloch to the Board, effective December 1, 2026. In conjunction with her appointment, the Board size will expand from 12 to 13 members. Ms. Knobloch will serve on the Board's Corporate Governance Committee and participate in the standard compensation program for non-employee directors.

Director Background & Strategic Fit

Ms. Knobloch brings substantial international corporate governance, digital media, and consumer leadership experience to Zoetis:

  • Current Roles: President of the Festival de Cannes (since July 2022) and Chair of the Board of Deezer S.A. (since January 2023).
  • Public Company Boards: Currently serves as a director of Lazard, Inc. (since April 2018) and Vail Resorts, Inc. (since February 2024), with past directorships including Accor S.A. and LVMH.
  • Executive Experience: Former senior executive at WarnerMedia, including President of WarnerMedia in France, Germany, Benelux, Austria, and Switzerland.

Governance and Compensation Highlights

  • Independence & Related Parties: Ms. Knobloch was not appointed pursuant to any third-party arrangement, and there are no reportable Item 404(a) related-party transactions.
  • Indemnification: Zoetis will enter into its standard form indemnification agreement with Ms. Knobloch.
  • Compensation: Ms. Knobloch will participate in Zoetis' standard non-employee director compensation program.

Market & Trading Impact

This filing does not involve any open-market purchases, dispositions, or immediate equity issuances. As an ordinary-course board expansion with the addition of an experienced independent director, the direct trading impact is expected to be neutral to low.

Topics:#Zoetis#ZTS#BoardOfDirectors#CorporateGovernance#AnimalHealth

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.